🦊/People

Roger Franklin

Investor

Partner at Hadean Ventures

Stockholm

Find your path to Roger

20 people in our graph share verified history with Roger — schools, employers, funds. One of them is your warm intro.

About

Roger Franklin trained as a scientist, completing doctoral work at Cambridge's Laboratory of Molecular Biology (LMB), and has since worked across venture capital, investment banking, and strategy consulting for nearly two decades. Before joining Hadean Ventures in 2018 to lead its Stockholm office, he was a pharmaceutical and biotechnology analyst at the investment bank Liberum in London. At Hadean, he focuses on therapeutic-space investments.

Contact· self-published, not guessed

Invests in

Biotech

Investments

Per the firm's website.

Colleagues at Hadean Ventures

Frequently asked questions

Who is Roger Franklin?
Roger Franklin trained as a scientist, completing doctoral work at Cambridge's Laboratory of Molecular Biology (LMB), and has since worked across venture capital, investment banking, and strategy consulting for nearly two decades. Before joining Hadean Ventures in 2018 to lead its Stockholm office, he was a pharmaceutical and biotechnology analyst at the investment bank Liberum in London. At Hadean, he focuses on therapeutic-space investments.
Where does Roger Franklin work?
Roger Franklin is Partner at Hadean Ventures.
What does Roger Franklin invest in?
Roger Franklin invests in Biotech.
What boards does Roger Franklin sit on?
Roger Franklin holds tracked board seats at Abliva, Cardior Pharmaceuticals, Complement Therapeutics, Contineum Therapeutics, Emergence Therapeutics, Gesynta Pharma, Step Pharma, TargED Biopharmaceuticals.